FindTrial
Sign In

recombinant interferon gamma

BIOLOGICAL15 trials

Sponsors

St. Vincent Medical Center - Los Angeles, Hoag Memorial Hospital Presbyterian, Memorial Sloan Kettering Cancer Center, Columbia University, National Cancer Institute (NCI)

Conditions

Breast CancerColorectal CancerGraft Versus Host DiseaseInfectionKidney CancerLeukemiaLung CancerLymphoma

Early Phase 1

Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma
TerminatedNCT01957709
Fred Hutchinson Cancer CenterMyxoid Liposarcoma, Round Cell Liposarcoma, Synovial Sarcoma
Start: 2013-09-25End: 2018-06-01Updated: 2019-07-10

Phase 1

Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer
TerminatedNCT00002796
National Cancer Institute (NCI)Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum, Recurrent Colon Cancer +7
Start: 1997-05-31Updated: 2013-02-01
Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer
CompletedNCT00004032
National Cancer Institute (NCI)Recurrent Ovarian Epithelial Cancer
Start: 1997-10-31Updated: 2013-01-23
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
WithdrawnNCT00002761
Columbia UniversityLeukemia
Start: 1996-02-29End: 2007-10-31Updated: 2012-11-19
Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors
CompletedNCT00004016
University of RochesterMelanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific
Start: 1999-04-30Updated: 2013-06-06
Biological Therapy in Treating Patients With Prostate Cancer
CompletedNCT00002637
Memorial Sloan Kettering Cancer CenterProstate Cancer
Start: 1995-01-31End: 2001-02-28Target: 25Updated: 2013-06-25

Phase 2

Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer
NCT00024271
Herbert Irving Comprehensive Cancer CenterMalignant Mesothelioma
Start: 2001-05-31Updated: 2014-01-06
Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
TerminatedNCT00006113
University of Southern CaliforniaMelanoma (Skin)
Start: 1999-06-30End: 2006-04-30Updated: 2014-05-22
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
CompletedNCT00002475
St. Vincent Medical Center - Los AngelesBreast Cancer, Colorectal Cancer, Kidney Cancer +3
Start: 1991-04-30End: 2009-06-30Target: 40Updated: 2013-07-10
Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections
CompletedNCT00059878
National Cancer Institute (NCI)Infection, Unspecified Adult Solid Tumor, Protocol Specific
Start: 2003-08-31End: 2005-01-31Updated: 2013-06-19
Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
CompletedNCT00070187
Children's Oncology GroupLymphoma
Start: 2003-11-30Updated: 2013-10-17
Tumor Cell Vaccine in Treating Patients With Advanced Cancer
CompletedNCT00002505
Hoag Memorial Hospital PresbyterianUnspecified Adult Solid Tumor, Protocol Specific
Start: 1992-08-31End: 2006-05-31Updated: 2011-05-12
Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma
CompletedNCT00616720
Mayo ClinicMultiple Myeloma and Plasma Cell Neoplasm
Start: 2001-08-31End: 2007-11-30Target: 15Updated: 2011-05-16

Phase 3

Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer
CompletedNCT00008203
Herbert Irving Comprehensive Cancer CenterBreast Cancer
Start: 1996-05-31End: 2008-05-31Updated: 2013-02-04
Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
CompletedNCT00003414
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsGraft Versus Host Disease, Lymphoma
Start: 1997-10-31End: 2004-05-31Target: 50Updated: 2015-07-20

Related Papers

Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapy
Journal for ImmunoTherapy of Cancer2020-04-0113 citations